NW
PYXS icon

NewEdge Wealth’s Pyxis Oncology PYXS Stock Holding History

NewEdge Wealth’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Hold
116,006
– – ﹤0.01% 983
2026
Q1 		$169K Hold
116,006
– – ﹤0.01% 1094
2025
Q4 		$133K Hold
116,006
– – ﹤0.01% 1167
2025
Q3 		$454K Hold
116,006
– – 0.01% 780
2025
Q2 		$124K Hold
116,006
– – ﹤0.01% 947
2025
Q1 		$114K Sell
116,006
-3
-0% -$4 ﹤0.01% 914
2024
Q4 		$181K Buy
116,009
+3
+0% +$9 ﹤0.01% 888
2024
Q3 		$426K Buy
+116,006
New +$406K 0.01% 654

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NewEdge Wealth's PYXS Position: Q2 2026 in Review

NewEdge Wealth held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 116,006 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #983.

NewEdge Wealth first reported a position in PYXS in Q3 2024 and has held it in 8 quarters since. The position peaked at $454K in Q3 2025. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • NewEdge Wealth held 116,006 shares of Pyxis Oncology worth $349K as of Q2 2026.
  • NewEdge Wealth left its Pyxis Oncology share count unchanged in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of NewEdge Wealth's portfolio in Q2 2026, its #983 holding.
  • NewEdge Wealth first reported a position in Pyxis Oncology in Q3 2024 and has held it in 8 quarters since.
  • NewEdge Wealth's Pyxis Oncology position peaked at $454K in Q3 2025.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.